A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main aim of this trial is to demonstrate that Evolocumab plus routine lipid management is superior to routine lipid management alone in modifying plaque (non-calcified) volume as measured by Artificial Intelligence-enabled Quantitative Coronary Plaque Analysis (AI-QCPA) from Coronary Computed Tomography Angiography (CCTA).
Epistemonikos ID: 651665d8ea7d32522b2fb0602fe8f436452c5f66
First added on: Sep 05, 2026